Viewing nowRosuzal 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Sae Han Pharmaceutical Co., Ltd.

MFDS item code 201804175 · Approved 2018.10.23 · Insurance code 651300920
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used as an adjunct therapy in patients with primary hypercholesterolemia or mixed dyslipidemia when diet and exercise alone do not provide sufficient control. It may also be used by patients with homozygous familial hypercholesterolemia in conjunction with diet or other treatment methods. It works by lowering total cholesterol and LDL-cholesterol levels, thereby slowing the progression of atherosclerosis. Specifically, it can also be used as an adjunct in pediatric patients aged 10 to 17 years who meet certain criteria for heterozygous familial hypercholesterolemia. It is beneficial for patients with primary dysbetalipoproteinemia and contributes positively to the reduction of cardiovascular disease risk. This medication reduces the risks of myocardial infarction, stroke, and revascularization procedures, thereby improving cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medication is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Safety and efficacy in children under 10 years of age have not been established.
This drug should not be used in certain patients. For example, patients who are allergic to this medication, those with severely impaired liver function, patients with muscle disorders, those with significantly reduced kidney function, and women who are pregnant or breastfeeding should not take this medication. In addition, high-dose use is prohibited in patients at high risk for muscle-related disorders, which include factors such as impaired kidney function, hypothyroidism, and a family history of muscle disease. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should avoid it. Patients with a history of liver disease or those who consume alcohol excessively should have regular liver function tests while using this medication. If symptoms such as myalgia, muscle weakness, or muscle damage occur, the doctor should be notified immediately, and blood tests may be necessary to assess the degree of muscle damage. This medication may cause increased liver enzyme levels in some patients, so treatment should be discontinued if there are signs of liver dysfunction. Caution is especially required in elderly patients, those with reduced kidney function, and patients with hypothyroidism, as they are at higher risk for muscle damage. This medication may interact with other drugs, so it is essential to inform the healthcare provider of any other medications being taken, as the risk of muscle damage may be increased when used with specific drugs. Women who are pregnant or may become pregnant should use appropriate contraception and should not take this medication during pregnancy. In case of overdose, there is no specific antidote, and management should focus on symptomatic treatment, along with liver function and muscle enzyme testing. Caution is advised when driving or operating machinery, as dizziness may occur. This medication may show higher systemic concentrations in Asians, so dose adjustment may be necessary. If severe skin reactions occur, the use of the medication should be stopped immediately and healthcare advice should be sought.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesic syndrome, memory impairment, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safest when stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent deterioration.
Pink round film-coated tablet
30 tablets/PTP(Alu-Alu) - 30 tablets/PTP[(Alu-Alu)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Sae Han Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.